Fairvalue-Calculator Fairvalue-Calculator
EN DE

Dentium CO., LTD (145720) Fair Value & Analysis

Healthcare · KR · Market cap 396B KRW

Price41,050 KRW
Fair Value51,019 KRW
Upside+24.3%
Quality95/100
Evidence: Medium Range 43,745 KRW – 69,278 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Dentium CO., LTD (145720) currently trades at 41,050 KRW, while our model-based Fair Value estimate is 51,019 KRW — implying the stock looks roughly 24.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Dentium CO., LTD (145720) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 51,019 KRW versus a price of 41,050 KRW — about +24% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 145720?
Our 21-model fair value for Dentium CO., LTD is 51,019 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 41,050 KRW.
What is the quality score of 145720?
Dentium CO., LTD has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.